IBAL Formulations Show Anticancer Effects

Oncology Research

Combination oncology is a cornerstone of cancer treatment because it helps target key pathways and creates an enhanced efficacy that one therapy could not. The use of anti-cancer drugs in combination can work synergistically or additively to treat the disease in different parts of the body while another may only affect specific areas.

August 18, 2021

IBAL Components Anticancer References

Public Relations

July 18, 2021

IBAL Component Cationic Zinc Anticancer References

Public Relations

July 18, 2021

IBAL Component Cationic Copper Anticancer References

Public Relations

April 15, 2018

Preliminary Evaluation Of ION-ZC1 As A Potential Anticancer Agent In Vitro

Public Relations

December 15, 2017

ION-ZC1 Topical Cream Anti-Tumor Efficacy Study - Syngeneic Mouse Melanoma - 30 Mice

Public Relations

August 15, 2016

ION-ZC1 Anti-Tumor Efficacy Study By Intravenous Injection - B16 Mouse Melanoma - 30 Mice

News Team

Are you interested in specific skin cancer?

READ MORE
selectmagnifiercrossmenu-circle